Brief: Obsidian Therapeutics - Files Prospectus Relates To Resale Of Up To 29,164,045 Shares Of Common Stock By Selling Stockholders- SEC Filing
28/08/2026 22:15
BRIEF-Obsidian Therapeutics - Files Prospectus Relates To Resale Of Up To 29,164,045 Shares Of Common Stock By Selling Stockholders- SEC Filing Aug 28 (Reuters) - Obsidian Therapeutics, Inc OBX.O:
OBSIDIAN THERAPEUTICS - FILES PROSPECTUS RELATES TO RESALE OF UP TO 29,164,045 SHARES OF COMMON STOCK BY SELLING STOCKHOLDERS- SEC FILING
Source text: []
Further company coverage: OBX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Obsidian Therapeutics
See all newsBrief: Obsidian Therapeutics - Files Prospectus Relates To Resale Of Up To 29,164,045 Shares Of Common Stock By Selling Stockholders- SEC Filing
NASDAQ RESUMED AT 09:40 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:31 AM
NASDAQ RESUMED AT 11:05 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:00 AM